Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Advisor
Help
Sign on to:
My DSpace
Receive email
updates
Edit Profile
Adelaide Research & Scholarship
Adelaide Research & Scholarship
Search
Search:
All collections
Schools and Disciplines
School of Medicine
Medicine
Medicine publications
for
Current filters:
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Start a new search
Add filters:
Use filters to refine the search results.
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Results 1-10 of 12 (Search time: 0.004 seconds).
previous
1
2
next
Item hits:
Preview
Issue Date
Title
Author(s)
2006
Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia
Druker, B.
;
Guilhot, F.
;
O'Brien, S.
;
Gathmann, I.
;
Kantarjian, H.
;
Gattermann, N.
;
Deininger, M.
;
Silver, R.
;
Goldman, J.
;
Stone, R.
;
Cervantes, F.
;
Hochhaus, A.
;
Powell, B.
;
Gabrilove, J.
;
Rousselot, P.
;
Reiffers, J.
;
Cornelissen, J.
;
Hughes, T.
;
Agis, H.
;
Fischer, T.
;
et al.
2020
Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML
DiNardo, C.D.
;
Tiong, I.S.
;
Quaglieri, A.
;
MacRaild, S.
;
Loghavi, S.
;
Brown, F.C.
;
Thijssen, R.
;
Pomilio, G.
;
Ivey, A.
;
Salmon, J.
;
Glytsou, C.
;
Fleming, S.A.
;
Zhang, Q.
;
Ma, H.
;
Patel, K.P.
;
Kornblau, S.M.
;
Xu, Z.
;
Chua, C.C.
;
Chen, X.
;
Blombery, P.
;
et al.
2015
Randomized phase II study of carboplatin and paclitaxel with either linifanib or placebo for advanced nonsquamous non–small-cell lung cancer
Ramalingam, S.S.
;
Shtivelband, M.
;
Soo, R.A.
;
Barrios, C.H.
;
Makhson, A.
;
Segalla, J.G.
;
Pittman, K.B.
;
Kolman, P.
;
Pereira, J.R.
;
Srkalovic, G.
;
Belani, C.P.
;
Axelrod, R.
;
Owonikoko, T.K.
;
Qin, Q.
;
Qian, J.
;
McKeegan, E.M.
;
Devanarayan, V.
;
McKee, M.D.
;
Ricker, J.L.
;
Carlson, D.M.
;
et al.
2021
Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma
Jacquelot, N.
;
Seillet, C.
;
Wang, M.
;
Pizzolla, A.
;
Liao, Y.
;
Hediyeh-Zadeh, S.
;
Grisaru-Tal, S.
;
Louis, C.
;
Huang, Q.
;
Schreuder, J.
;
Souza-Fonseca-Guimaraes, F.
;
de Graaf, C.A.
;
Thia, K.
;
Macdonald, S.
;
Camilleri, M.
;
Luong, K.
;
Zhang, S.
;
Chopin, M.
;
Molden-Hauer, T.
;
Nutt, S.L.
;
et al.
2021
Health-Related Quality of Life in Metastatic, Hormone-Sensitive Prostate Cancer: ENZAMET (ANZUP 1304), an International, Randomized Phase III Trial Led by ANZUP
Stockler, M.R.
;
Martin, A.J.
;
Davis, I.D.
;
Dhillon, H.M.
;
Begbie, S.D.
;
Chi, K.N.
;
Chowdhury, S.
;
Coskinas, X.
;
Frydenberg, M.
;
Hague, W.E.
;
Horvath, L.G.
;
Joshua, A.M.
;
Lawrence, N.J.
;
Marx, G.M.
;
McCaffrey, J.
;
McDermott, R.
;
McJannett, M.
;
North, S.A.
;
Parnis, F.
;
Parulekar, W.R.
;
et al.
2013
Phase III randomized, placebo-controlled study of cetuximab plus brivanib alaninate versus cetuximab plus placebo in patients with metastatic, chemotherapy-refractory, wild-type K-RAS colorectal carcinoma: The NCIC clinical trials group and AGITG co.
Siu, L.
;
Shapiro, J.
;
Jonker, D.
;
Karapetis, C.
;
Zalcberg, J.
;
Simes, J.
;
Couture, F.
;
Moore, M.
;
Price, T.
;
Siddiqui, J.
;
Nott, L.
;
Charpentier, D.
;
Liauw, W.
;
Sawyer, M.
;
Jefford, M.
;
Magoski, N.
;
Haydon, A.
;
Walters, I.
;
Ringash, J.
;
Tu, D.
;
et al.
2019
Enzalutamide with standard first-line therapy in metastatic prostate cancer
Davis, I.D.
;
Martin, A.J.
;
Stockler, M.R.
;
Begbie, S.
;
Chi, K.N.
;
Chowdhury, S.
;
Coskinas, X.
;
Frydenberg, M.
;
Hague, W.E.
;
Horvath, L.G.
;
Joshua, A.M.
;
Lawrence, N.J.
;
Marx, G.
;
McCaffrey, J.
;
McDermott, R.
;
McJannett, M.
;
North, S.A.
;
Parnis, F.
;
Parulekar, W.
;
Pook, D.W.
;
et al.
2017
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
Weller, M.
;
Butowski, N.
;
Tran, D.D.
;
Recht, L.D.
;
Lim, M.
;
Hirte, H.
;
Ashby, L.
;
Mechtler, L.
;
Goldlust, S.A.
;
Iwamoto, F.
;
Drappatz, J.
;
O'Rourke, D.M.
;
Wong, M.
;
Hamilton, M.G.
;
Finocchiaro, G.
;
Perry, J.
;
Wick, W.
;
Green, J.
;
He, Y.
;
Turner, C.D.
;
et al.
2012
Pemetrexed versus pemetrexed and carboplatin as second-line chemotherapy in advanced non-small-cell lung cancer: Results of the GOIRC 02-2006 randomized phase II study and pooled analysis with the NVALT7 trial
Ardizzoni, A.
;
Tiseo, M.
;
Boni, L.
;
Vincent, A.
;
Passalacqua, R.
;
Buti, S.
;
Amoroso, D.
;
Camerini, A.
;
Labianca, R.
;
Genestreti, G.
;
Boni, C.
;
Ciuffreda, L.
;
Di Costanzo, F.
;
De Marinis, F.
;
Crino, L.
;
Santo, A.
;
Pazzola, A.
;
Barbieri, F.
;
Zilembo, N.
;
Colantonio, I.
;
et al.
2015
A phase I/II trial of BNC105P with everolimus in metastatic renal cell carcinoma
Pal, S.
;
Azad, A.
;
Bhatia, S.
;
Drabkin, H.
;
Costello, B.
;
Sarantopoulos, J.
;
Kanesvaran, R.
;
Lauer, R.
;
Starodub, A.
;
Hauke, R.
;
Sweeney, C.
;
Hahn, N.
;
Sonpavde, G.
;
Richey, S.
;
Breen, T.
;
Kremmidiotis, G.
;
Leske, A.
;
Doolin, E.
;
Bibby, D.
;
Simpson, J.
;
et al.
Discover
Author
2
Cervantes, F.
2
Chi, K.N.
2
Chowdhury, S.
2
Cornelissen, J.
2
Coskinas, X.
2
Davis, I.D.
2
Fischer, T.
2
Frydenberg, M.
2
Gathmann, I.
2
Goldman, J.
.
next >
Subject
11
Humans
11
Male
8
Aged
8
Female
8
Middle Aged
6
Adult
5
Disease-Free Survival
5
Kaplan-Meier Estimate
5
Treatment Outcome
3
Aged, 80 and over
.
next >
Date issued
3
2020 - 2021
7
2010 - 2019
2
2003 - 2009